NM_005629.4:c.1496-4G>A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_005629.4(SLC6A8):​c.1496-4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000194 in 1,205,776 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 76 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.00020 ( 0 hom. 74 hem. )

Consequence

SLC6A8
NM_005629.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00007542
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.71

Publications

0 publications found
Variant links:
Genes affected
SLC6A8 (HGNC:11055): (solute carrier family 6 member 8) The protein encoded by this gene is a plasma membrane protein whose function is to transport creatine into and out of cells. Defects in this gene can result in X-linked creatine deficiency syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
SLC6A8 Gene-Disease associations (from GenCC):
  • creatine transporter deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant X-153694529-G-A is Benign according to our data. Variant chrX-153694529-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 436770.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A8NM_005629.4 linkc.1496-4G>A splice_region_variant, intron_variant Intron 10 of 12 ENST00000253122.10 NP_005620.1 P48029-1X5D9C4
SLC6A8NM_001142805.2 linkc.1466-4G>A splice_region_variant, intron_variant Intron 10 of 12 NP_001136277.1 P48029Q59EV7
SLC6A8NM_001142806.1 linkc.1151-4G>A splice_region_variant, intron_variant Intron 10 of 12 NP_001136278.1 P48029-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A8ENST00000253122.10 linkc.1496-4G>A splice_region_variant, intron_variant Intron 10 of 12 1 NM_005629.4 ENSP00000253122.5 P48029-1

Frequencies

GnomAD3 genomes
AF:
0.000108
AC:
12
AN:
110972
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000658
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000189
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000152
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000984
AC:
18
AN:
182957
AF XY:
0.000177
show subpopulations
Gnomad AFR exome
AF:
0.0000761
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000723
Gnomad FIN exome
AF:
0.0000625
Gnomad NFE exome
AF:
0.000172
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000203
AC:
222
AN:
1094752
Hom.:
0
Cov.:
34
AF XY:
0.000205
AC XY:
74
AN XY:
360490
show subpopulations
African (AFR)
AF:
0.000114
AC:
3
AN:
26327
American (AMR)
AF:
0.00
AC:
0
AN:
35198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19364
East Asian (EAS)
AF:
0.0000994
AC:
3
AN:
30189
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54062
European-Finnish (FIN)
AF:
0.0000494
AC:
2
AN:
40455
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4103
European-Non Finnish (NFE)
AF:
0.000250
AC:
210
AN:
839079
Other (OTH)
AF:
0.0000653
AC:
3
AN:
45975
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000108
AC:
12
AN:
111024
Hom.:
0
Cov.:
23
AF XY:
0.0000601
AC XY:
2
AN XY:
33260
show subpopulations
African (AFR)
AF:
0.0000656
AC:
2
AN:
30473
American (AMR)
AF:
0.000189
AC:
2
AN:
10584
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2634
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3505
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2621
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6038
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.000152
AC:
8
AN:
52757
Other (OTH)
AF:
0.00
AC:
0
AN:
1519
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.0000718
EpiCase
AF:
0.000491
EpiControl
AF:
0.000296

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 01, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC6A8: BP4, BS2 -

not specified Benign:1
Jun 28, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Creatine transporter deficiency Benign:1
Sep 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SLC6A8-related disorder Benign:1
Sep 10, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.060
DANN
Benign
0.48
PhyloP100
-3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000075
dbscSNV1_RF
Benign
0.16
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782589547; hg19: chrX-152959984; API